UBS’s Psychemedics Corporation PMD Stock Holding History

UBS’s Portfolio PMD Stock Details PMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$144K	Buy	10,171 +9,218	+967%	+$131K	﹤0.01%	5542
2014 Q2	$14K	Sell	953 -210	-18%	-$3.19K	﹤0.01%	8536
2014 Q1	$19K	Buy	1,163 +960	+473%	+$15.9K	﹤0.01%	8174
2013 Q4	$3K	Sell	203 -1,110	-85%	-$15.3K	﹤0.01%	9894
2013 Q3	$18K	Buy	1,313 +399	+44%	+$4.96K	﹤0.01%	8207
2013 Q2	$10K	Buy	+914	New	+$10.3K	﹤0.01%	8652

Other funds holding PMD

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TCM

Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAIM

Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

KFA

Kelleher Financial Advisors New York $395M AUM 12.89% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

NSIM

North Star Investment Management Chicago, Illinois $1.65B AUM 20.56% 1-Year Est. Return

CIC

Crawford Investment Counsel Atlanta, Georgia $5.85B AUM 12.61% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

UBS's PMD Position: Q3 2014 in Review

UBS increased its Psychemedics Corporation (PMD) stake by 967% in Q3 2014, buying an estimated $131K and bringing the position to 10,171 shares worth $144K. The position accounts for ﹤0.01% of the portfolio, ranked #5542.

UBS first reported a position in PMD in Q2 2013 and has held it in 6 quarters since. 33 funds tracked by Wall St. Rank hold PMD as of Q3 2014.

UBS held 10,171 shares of Psychemedics Corporation worth $144K as of Q3 2014.
UBS bought 9,218 Psychemedics Corporation shares in Q3 2014, an estimated $131K.
Psychemedics Corporation made up ﹤0.01% of UBS's portfolio in Q3 2014, its #5542 holding.
UBS first reported a position in Psychemedics Corporation in Q2 2013 and has held it in 6 quarters since.
33 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.